- Topical Atropine for Myopia Management: What Does the Latest Research Tell Us?
- Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control
- Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness.
- Topical Atropine in the Control of Myopia
- Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops
- Zone geometry, pupil size may affect accommodation in multifocal contacts
- Natural Ways of Myopia Control: A Public Health Approach for the Prevention of Myopia
- BCLA Statement: International Myopia Institute (IMI) Myopia Reports
Keen Eyecare Consultants Inc
- Dr. Jacob Schmitt O.D. - - Dr. Stefan Hanish O.D. -